Vascular surgical procedure remains often invasive and needs prolonged hospital stays. Conventional vascular surgery comprises of opening the body, cutting vessels, and closing it by means of sutures, it consist of procedures such as carotid endarterectomy, open abdominal aneurysm repair and lower extremity bypass surgery. In contrast, majority of vascular graft procedures are usually are minimally invasive besides involve repairing vessels from inside. Catheter-based devices are introduced through a minor incision and are directed with the aid of real-time imaging technologies. Typical endovascular procedures comprises of stenting, angioplasty, stent-grafting, and atherectomy.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/1801
Vascular graft is a medical procedure that is done to redirect the flow of blood in an area of the body and is generally performed due to the insufficient blood flow and as a part of organ transplantation. In general, a person’s own vein is chosen as a graft material or other synthetic materials such as Dacron, ePTFE or a different person’s vein are also generally used. Moreover, can also be redirected and serve as vascular grafts. An ideal vascular graft consist of the following characteristics such as appropriate size to match the host vessels, rapid healing, ease of handling, increased porosity, resistance to infection, low thrombogenicity and economical
The global vascular graft market is segmented based on types, products, application and geography. The vascular grafts are of various types such as autologous, preserved autologous and synthetic. The autologous includes saphenous veins and radial artery; preserved autologous includes cryopreserved veins, whereas the synthetic grafts consist of PTFE, Teflon and Dacron. The PTFE has gained more popularity over Dacron due to the better tissue adhesion, improved pliability and lack of requirement to preclot prior to implantation. The products include endovascular stent graft, peripheral vascular graft, hemodialysis access graft and coronary artery bypass graft. The endovascular stent graft is known to have a largest market share in this segment due to high volume of EVAR (endovascular aortic repair) procedures. The applications include cardiovascular diseases, kidney failure, vascular occlusion, aneurysm, diabetes and others.
Inquiry on this report @ http://www.mrrse.com/enquiry/1801
Based on the geography, market segmentation is North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominates the vascular graft market due to the presence of advanced healthcare infrastructures, reimbursement policies and adoption of new innovative products. However, Asia Pacific is expected to be the fastest growing in the vascular graft market due to the government initiatives and fast development in the research facilities.
Some of the factors such as rise in the healthcare expenditures, increasing demand of minimally invasive procedures, increase in the prevalence of cardiovascular diseases, ageing population are some of factors responsible to drive the global vascular graft market. However, sometime the failure of the products and alternative therapies acts as a restrain or hinders the growth of the market. The rise in the unhealthy lifestyle of the people and reimbursement policies in the developed nations will create an opportunity to vascular graft market.
Read Complete Report with TOC @ http://www.mrrse.com/vascular-graft-market
Some of the key players in the vascular graft market are Medtronic Plc., Bard Peripheral Vascular Inc., W.L. Gore & Associates, Inc., Cook Medical, LeMaitre Vascular Inc. Humacyte, Inc. and Terumo Medical Corporation, and B. Braun.
90 State Street,
Albany NY – 12207